Blog | Monday, October 15, 2012

QD: News Every Day--HPV4 vaccination research finds no risks beyond the injection itself

There are no new concerns to administering the HPV vaccines other than what was known, same-day syncope and skin infections within two weeks of vaccination, both of which were known for teenage girls receiving shots, a study found.

Researchers at Kaiser Permanente studied nearly 190,000 women who received at least one of the three doses of HPV4 from August 2006 to March 2008 and looked for emergency department visits and hospitalizations.

Among 50 different criteria examined, only skin infections two weeks after the injection (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.3 to 2.4) and syncope on day of vaccination (OR, 6.0; 95% CI, 3.9 to 9.2) had likely associations.
The study, which appeared in the Archives of Pediatrics & Adolescent Medicine was required by the FDA and funded by the drug's manufacturer.

Previous research showed that girls are more likely than adult women to report side effects, and that the vaccine doesn't trigger lupus, rheumatoid arthritis, diabetes or multiple sclerosis.